Gilead Sciences, Inc. (GILD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 152.69B |
| Enterprise Value | 170.06B |
| P/E Ratio | -55.12 |
| PEG Ratio | 0.42 |
| Price/Sales Ratio | 6.84 |
| Price/Book Ratio | 16.28 |
| Enterprise/Revenue | 7.48 |
| Enterprise/EBITDA | 179.36 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.12 |
| Operating Margin | 0.38 |
| Return On Assets | -0.08 |
| Return On Equity | -0.22 |
| Revenue | 29.44B |
| Revenue/Share | 24.95 |
| Gross Profit | 23.21B |
| EBITDA | 13.58B |
| Net Income | 8.51B |
| Diluted EPS | 6.78 |
| Total Cash | 6.44B |
| Total Cash/Share | 5.18 |
| Total Debt | 26.23B |
| Total Debt/Equity | 2.01 |
| Current Ratio | 1.38 |
| Book Value Per Share | 10.43 |
| 52-Week Change | 44.62 |
| 52-Week High | 176.58 |
| 52-Week Low | 116.88 |
| Moving Average 50 Days | 153.51 |
| Moving Average 200 Days | 141.13 |
| Average Volume | 6.01M |
| Shares Outstanding | 1.24B |
| % Held by Institutions | 90.19 |
| Trailing Annual Dividend Rate | 3.25 |
| Trailing Annual Dividend Yield | 1.9 |
| Payout Ratio | -1.06 |
| Last Split Factor | 2:1 |
| Last Split Date | January 28, 2013 |